NEW YORK, Dec. 17, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ASP Isotopes Inc. ("ASP Isotopes Inc." or the "Company") (NASDAQ: ASPI) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ASP Isotopes Inc. investors who were adversely affected by alleged securities fraud between October 30, 2024 and November 26, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/asp-isoto ...

WASHINGTON, Dec. 16, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today released the following letter to shareholders from its Chairman and CEO, Paul Mann. Dear Fellow Shareholder, As the year comes towards its end, I wanted to personally write to you to summarize some of the more significant milestones the Compa ...

NEW YORK, Dec. 16, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of ASP Isotopes Inc. (NASDAQ: ASPI).Shareholders who purchased shares of ASPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE: https://securitiesclasslaw.com/securities/asp-isotopes-inc-loss-submission-form/?id=116404&from=4 CLASS PERIOD: October 30, 2024 ...

Core Viewpoint - ASP Isotopes Inc. strongly refutes the claims made by short seller Fuzzy Panda, asserting that the report contains inaccuracies and misleading conclusions about the company's technologies and business operations [2][22]. Company Technology - The company emphasizes that its quantum enrichment technology is significantly different from outdated AVLIS technology, featuring advanced spectroscopy and laser systems [4][6]. - ASP Isotopes has successfully produced semi-finished enriched Ytterbium-176 and expects to achieve 99.75% enrichment for commercial sale in 2025 [4][22]. - The company’s aerodynamic separation process technology is currently operational in South Africa for the enrichment of Carbon-14 and Silicon-28, which was not mentioned in Fuzzy Panda's report [7][19]. Business Developments - ASP Isotopes has entered a term sheet with TerraPower for the construction of a uranium enrichment facility, which is expected to produce HALEU and is not a zero-cost agreement as claimed by Fuzzy Panda [8][9]. - A memorandum of understanding with the South African Nuclear Energy Corporation (Necsa) has been signed to collaborate on advanced nuclear fuel production, with plans for a new entity to be formed in South Africa [9][12]. Regulatory and Licensing - The company clarifies that it does not require a U.S. Nuclear Regulatory Commission license for uranium enrichment activities in South Africa, as the local regulatory framework will apply [11][12]. - ASP Isotopes is committed to obtaining all necessary permits and licenses for its uranium enrichment operations in South Africa [12]. Intellectual Property - The company relies on trade secrets and non-disclosure agreements for intellectual property protection, as patenting sensitive nuclear technologies is complex and often not feasible [13][14]. - ASP Isotopes has not pursued patents due to the sensitive nature of its technology and the potential limitations on public disclosure [14]. Financial Performance - Fuzzy Panda's claims regarding PET Labs' financial losses are incorrect; the company has generated positive EBITDA in recent years [15]. - The acquisition of PET Labs was not made to a related party, countering Fuzzy Panda's assertions [15]. Company Operations - ASP Isotopes has a minimal physical presence in the U.S. and operates primarily from South Africa, where it is commissioning three isotope enrichment facilities [16][19]. - The company has approximately 126 employees in South Africa, with a focus on research, development, and manufacturing [19]. Investor Relations - The company values transparency and plans to host an Investor Access Event in South Africa in January 2025 to engage with investors [21][22]. - ASP Isotopes' stockholder base includes approximately 31% institutional investors, indicating a reputable investor profile [20].

WASHINGTON, Dec. 13, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today issued the following statement in response to short seller Fuzzy Panda's purported "report" published on November 26, 2024. Executive Chairman and Chief Executive Officer, Paul Mann, stated: "Fuzzy Panda is known for these types of short attack ...

Core Viewpoint - A class action securities lawsuit has been filed against ASP Isotopes Inc. due to alleged securities fraud affecting investors between October 30, 2024, and November 26, 2024 [1][2]. Group 1: Allegations - The lawsuit claims that ASP Isotopes Inc. made false statements regarding the effectiveness of its enrichment technology [2]. - It is alleged that the company overstated the development potential of its high assay low-enriched uranium facility [2]. - The complaint also states that the company misrepresented the results of its nuclear fuels operating segment [2]. - As a result of these misrepresentations, the positive statements made by the defendants about the company's business and prospects were materially misleading [2]. Group 2: Legal Process - Investors who suffered losses during the specified time frame have until February 3, 2025, to request to be appointed as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff to share in any potential recovery [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].

SAN FRANCISCO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) and certain of its most senior executives are now entangled in a securities class action, alleging the company deceived investors by making false and misleading statements about its advanced nuclear fuel technologies. Hagens Berman urges investors in ASP Isotopes who suffered substantial losses to submit your losses now. Class Period: Oct. 30, 2024 – Nov. 26, 2024Lead Plaintiff Deadline: Feb. 3, 2025Visit: www.hbsslaw.com/inve ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In ASP Isotopes To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $50,000 in ASP Isotopes between October 30, 2024 and November 26, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, Dec. 12, 2024 ...

NEW YORK, Dec. 12, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of ASP Isotopes Inc. (NASDAQ: ASPI).Shareholders who purchased shares of ASPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/asp-isotopes-inc-loss-submission-form/?id=115955&from=4 CLASS PERIOD: October 30, 2024 ...

Core Viewpoint - A class action lawsuit has been filed against ASP Isotopes Inc. on behalf of shareholders who purchased securities between October 30, 2024, and November 26, 2024, due to alleged misleading statements regarding the company's technology and operational results [1][5]. Group 1: Lawsuit Details - The lawsuit claims that ASP Isotopes made materially false and misleading statements about its enrichment technology, development potential of its uranium facility, and the results of its nuclear fuels operating segment [5]. - Investors are entitled to compensation without any out-of-pocket fees through a contingency fee arrangement if they purchased ASP Isotopes securities during the class period [2]. Group 2: Legal Representation - The Rosen Law Firm, known for its success in securities class actions, is representing the investors and encourages them to select qualified counsel with a proven track record [4]. - A lead plaintiff must move the Court by February 3, 2025, to represent other class members in the litigation [3].